Clinical studies show that weight lost with GLP-1 agonists comprises both adipose tissue and lean body mass
Evidence is mixed and context-dependent, so diet, training, and total calories still matter most
Not only in the skin, when applied topically, but also throughout the entire body when injected
The proportion of patients achieving HbA1c of less than 7 % without severe or confirmed episodes of hypoglycaemia and without weight gain was significantly higher with semaglutide at doses of 0.5 mg and 1 mg (up to 66 % and 74 %, respectively) versus patients treated with sitagliptin (27 %), exenatide ER (29 %), insulin glargine (16%), dulaglutide 0.75 mg (44 %) and dulaglutide 1.5 mg (58 %)
Get this step right, and every dose that follows is accurate
CrossRef Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions Janthakan Wongsuwan, Teeravut Tubtawee, Sitang Nirattisaikul, Pojsakorn Danpanichkul, Wisit Cheungpasitporn, Sitthichok Chaichulee, Apichat Kaewdech BMJ Open Gastroenterology .2025
